Advertisement
Screener

Neurogene Inc. (NGNE) Finance Lease, Principal Payments

2.8 / 5 stars · 68/120 Roast Me

Neurogene Inc. Finance Lease, Principal Payments

Neurogene Inc. (NGNE) reported Finance Lease, Principal Payments of $11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Financing Activities

us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-11

  • Neurogene Inc. finance lease, principal payments for the quarter ending 2026-06-30 was $5.00K, a 64.29% decline year-over-year.
  • Neurogene Inc. finance lease, principal payments for the quarter ending 2026-03-31 was $6.00K, a 60.00% decline year-over-year.
  • Neurogene Inc. finance lease, principal payments for the quarter ending 2025-12-31 was $19.00K, a 46.15% increase year-over-year.
  • Neurogene Inc. finance lease, principal payments for the quarter ending 2025-09-30 was $13.00K, a 8.33% increase year-over-year.
  • Neurogene Inc. finance lease, principal payments for fiscal 2025 was $61.00K, a 17.31% increase from fiscal 2024.
  • Neurogene Inc. finance lease, principal payments for fiscal 2024 was $52.00K, a 79.31% increase from fiscal 2023.
  • Neurogene Inc. finance lease, principal payments for fiscal 2023 was $29.00K, a 2800.00% increase from fiscal 2022.
  • Neurogene Inc. finance lease, principal payments for fiscal 2022 was $1.00K, a 98.04% decline from fiscal 2021.
Period endFinance Lease, Principal Payments 3 monthFinance Lease, Principal Payments 3 month as first filedFinance Lease, Principal Payments 6 monthFinance Lease, Principal Payments 6 month as first filedFinance Lease, Principal Payments 9 monthFinance Lease, Principal Payments 9 month as first filedFinance Lease, Principal Payments 12 monthFinance Lease, Principal Payments 12 month as first filed
2026-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$11.00K
10-Q · filed 2026-08-11
$30.00K
derived: sum of 3 quarters · filed 2026-08-11
$43.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31$6.00K
10-Q · filed 2026-05-12
$25.00K
derived: sum of 2 quarters · filed 2026-05-12
$38.00K
derived: sum of 3 quarters · filed 2026-05-12
$52.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$32.00K
derived: sum of 2 quarters · filed 2026-03-24
$46.00K
derived: sum of 3 quarters · filed 2026-08-11
$61.00K
10-K · filed 2026-03-24
2025-09-30$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$27.00K
derived: sum of 2 quarters · filed 2026-08-11
$42.00K
10-Q · filed 2025-11-13
$55.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$29.00K
10-Q · filed 2026-08-11
$42.00K
derived: sum of 3 quarters · filed 2026-08-11
$54.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$15.00K
10-Q · filed 2026-05-12
$28.00K
derived: sum of 2 quarters · filed 2026-05-12
$40.00K
derived: sum of 3 quarters · filed 2026-05-12
$56.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$25.00K
derived: sum of 2 quarters · filed 2026-03-24
$41.00K
derived: sum of 3 quarters · filed 2026-03-24
$52.00K
10-K · filed 2026-03-24
2024-09-30$12.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$28.00K
derived: sum of 2 quarters · filed 2025-11-13
$39.00K
10-Q · filed 2025-11-13
$47.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$16.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$27.00K
10-Q · filed 2025-08-11
$35.00K
derived: sum of 3 quarters · filed 2025-08-11
$45.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$11.00K
10-Q · filed 2025-05-09
$19.00K
derived: sum of 2 quarters · filed 2025-05-09
$29.00K
derived: sum of 3 quarters · filed 2025-05-09
$35.00K
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$18.00K
derived: sum of 2 quarters · filed 2025-03-24
$24.00K
derived: sum of 3 quarters · filed 2025-03-24
$29.00K
10-K · filed 2025-03-24
2023-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18
$16.00K
derived: sum of 2 quarters · filed 2024-11-18
$21.00K
10-Q · filed 2024-11-18
$365.00K
10-Q · filed 2023-11-14
-$32.00K
derived: sum of 4 quarters · filed 2024-11-18
2023-06-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$11.00K
10-Q · filed 2024-08-09
$364.00K
10-Q · filed 2023-08-10
-$42.00K
derived: sum of 3 quarters · filed 2024-08-09
$10.00K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$5.00K
10-Q · filed 2024-05-10
$66.00K
10-Q · filed 2023-05-08
-$48.00K
derived: sum of 2 quarters · filed 2024-05-10
$4.00K
derived: sum of 3 quarters · filed 2024-05-10
$5.00K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
-$1.00K
derived: sum of 2 quarters · filed 2024-03-18
$0.00
derived: sum of 3 quarters · filed 2024-03-18
$1.00K
10-K · filed 2024-03-18
$55.00K
10-K · filed 2023-03-20
2022-09-30$52.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$53.00K
derived: sum of 2 quarters · filed 2023-11-14
$54.00K
10-Q · filed 2023-11-14
$103.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$2.00K
10-Q · filed 2023-08-10
$51.00K
derived: sum of 3 quarters · filed 2023-08-10
$51.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$1.00K
10-Q · filed 2023-05-08
$50.00K
derived: sum of 2 quarters · filed 2023-05-08
$50.00K
derived: sum of 3 quarters · filed 2023-05-08
$52.00K
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$49.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
$49.00K
derived: sum of 2 quarters · filed 2023-03-20
$51.00K
derived: sum of 3 quarters · filed 2023-03-20
$51.00K
10-K · filed 2023-03-20
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$2.00K
derived: sum of 2 quarters · filed 2022-11-14
$2.00K
10-Q · filed 2022-11-14
$2.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$2.00K
10-Q · filed 2022-08-09
$2.00K
derived: sum of 3 quarters · filed 2022-08-09
$47.00K
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$0.00
10-Q · filed 2022-05-09
$0.00
derived: sum of 2 quarters · filed 2022-05-09
$45.00K
derived: sum of 3 quarters · filed 2022-05-09
$47.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$45.00K
derived: sum of 2 quarters · filed 2022-03-01
$47.00K
derived: sum of 3 quarters · filed 2022-03-01
$49.00K
10-K · filed 2022-03-01
2020-09-30$45.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$47.00K
derived: sum of 2 quarters · filed 2021-11-04
$49.00K
10-Q · filed 2021-11-04
$51.00K
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$4.00K
10-Q · filed 2021-08-05
$6.00K
derived: sum of 3 quarters · filed 2021-08-05
$8.00K
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$2.00K
10-Q · filed 2021-05-12
$4.00K
derived: sum of 2 quarters · filed 2021-05-12
$6.00K
derived: sum of 3 quarters · filed 2021-05-12
$8.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$4.00K
derived: sum of 2 quarters · filed 2021-03-25
$6.00K
derived: sum of 3 quarters · filed 2021-03-25
$9.00K
10-K · filed 2021-03-25
2019-09-30$2.00K
10-Q · filed 2019-11-13
$4.00K
derived: sum of 2 quarters · filed 2020-08-12
$7.00K
10-Q · filed 2020-11-09
2019-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$4.00K
10-Q · filed 2020-08-12
2019-03-31$2.00K
10-Q · filed 2020-05-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76